Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine versus sufentanil for patient-controlled intravenous analgesia after thoracoscopic pulmonary lobectomy
ChiCTR2400084600Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Jiangnan University
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oliceridine and sufentanil in postoperative pain (3 arms), sponsored by Affiliated Hospital of Jiangnan University. Primary endpoints: VAS score, Ramsay sedation score and 4 more. Planned start May 2024; status: not yet recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400084600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084600.